NuGo Slim Crunchy Peanut Butter Protein Bar, 5g net carbs, A gluten-free, soy protein bar with overall peanut butter and chocolate taste ...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2094-2017.
Undeclared milk allergen. Brownie Bar packaged in Crunchy Peanut Butter Bar wrapper which does not list milk as an allergen under allergen information section of the ingredient statement.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2094-2017.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Nugo Nutrition Hq or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2094-2017.
NuGo Nutrition HQ
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Nugo Nutrition Hq Recall FAQ
Nugo Nutrition Hq is the subject of a dairy safety report: NuGo Slim Crunchy Peanut Butter Protein Bar, 5g net carbs, A gluten-free, soy protein bar with overall peanut butter and chocolate taste .... The notice was published on March 28, 2016 by the U.S. Food and Drug Administration (FDA). Approximately 1,165 units are potentially affected.